These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8529818)

  • 1. Empirical modeling of particle deposition in the alveolar region of the lungs: a basis for interspecies extrapolation.
    Asgharian B; Wood R; Schlesinger RB
    Fundam Appl Toxicol; 1995 Sep; 27(2):232-8. PubMed ID: 8529818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric adjustments for interspecies extrapolation of inhaled poorly soluble particles (PSP).
    Jarabek AM; Asgharian B; Miller FJ
    Inhal Toxicol; 2005; 17(7-8):317-34. PubMed ID: 16020031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes.
    Lalas A; Nousias S; Kikidis D; Lalos A; Arvanitis G; Sougles C; Moustakas K; Votis K; Verbanck S; Usmani O; Tzovaras D
    BMC Med Inform Decis Mak; 2017 Dec; 17(Suppl 3):173. PubMed ID: 29297393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of regional deposition dosage for inhaled nanoparticles in human and rat olfactory.
    Tian L; Shang Y; Chen R; Bai R; Chen C; Inthavong K; Tu J
    Part Fibre Toxicol; 2019 Jan; 16(1):6. PubMed ID: 30683122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species comparisons of proximal alveolar deposition patterns of inhaled particulates.
    Warheit DB; Hartsky MA
    Exp Lung Res; 1990; 16(2):83-99. PubMed ID: 2328713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling age-related particle deposition in humans.
    Asgharian B; Ménache MG; Miller FJ
    J Aerosol Med; 2004; 17(3):213-24. PubMed ID: 15625813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
    Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
    Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of heterogeneity of lung structure on particle deposition in the rat lung.
    Hofmann W; Asgharian B; Bergmann R; Anjilvel S; Miller FJ
    Toxicol Sci; 2000 Feb; 53(2):430-7. PubMed ID: 10696791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational modeling of nanoscale and microscale particle deposition, retention and dosimetry in the mouse respiratory tract.
    Asgharian B; Price OT; Oldham M; Chen LC; Saunders EL; Gordon T; Mikheev VB; Minard KR; Teeguarden JG
    Inhal Toxicol; 2014 Dec; 26(14):829-42. PubMed ID: 25373829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive models for deposition of inhaled diesel exhaust particles in humans and laboratory species.
    Yu CP; Xu GB
    Res Rep Health Eff Inst; 1987; (10):3-22. PubMed ID: 2478161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition and clearance of inhaled particles.
    Stuart BO
    Environ Health Perspect; 1984 Apr; 55():369-90. PubMed ID: 6376108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical analysis of particle deposition in human lungs: an improved single path transport model.
    Choi JI; Kim CS
    Inhal Toxicol; 2007 Sep; 19(11):925-39. PubMed ID: 17849277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric principles for extrapolating results of rat inhalation studies to humans, using an inhaled Ni compound as an example.
    Oberdörster G
    Health Phys; 1989; 57 Suppl 1():213-20. PubMed ID: 2606684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Airflow and Particle Deposition in a Human Acinar Region.
    Kolanjiyil AV; Kleinstreuer C
    Comput Math Methods Med; 2019; 2019():5952941. PubMed ID: 30755779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposition, retention, and clearance of inhaled particles.
    Lippmann M; Yeates DB; Albert RE
    Br J Ind Med; 1980 Nov; 37(4):337-62. PubMed ID: 7004477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow and Particle Deposition in Acinar Models with Interalveolar Septal Walls and Different Alveolar Numbers.
    Xi J; Talaat M; Tanbour H; Talaat K
    Comput Math Methods Med; 2018; 2018():3649391. PubMed ID: 30356402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation reference dose (RfDi): an application of interspecies dosimetry modeling for risk assessment of insoluble particles.
    Jarabek AM; Menache MG; Overton JH; Dourson ML; Miller FJ
    Health Phys; 1989; 57 Suppl 1():177-83. PubMed ID: 2606680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.
    Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):423-31. PubMed ID: 25826480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition.
    Schmid O; Bolle I; Harder V; Karg E; Takenaka S; Schulz H; Ferron GA
    J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):291-307. PubMed ID: 18627243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.